Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Safety-net Providers | 6 | 2024 | 55 | 1.430 |
Why?
|
| Carcinoma, Hepatocellular | 10 | 2024 | 2191 | 0.940 |
Why?
|
| Pancreaticoduodenectomy | 10 | 2022 | 703 | 0.810 |
Why?
|
| Liver Neoplasms | 11 | 2024 | 4839 | 0.720 |
Why?
|
| Drainage | 7 | 2019 | 460 | 0.690 |
Why?
|
| Pancreatectomy | 9 | 2022 | 690 | 0.650 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 819 | 0.450 |
Why?
|
| Granulomatous Mastitis | 1 | 2013 | 9 | 0.450 |
Why?
|
| Hospitals, County | 1 | 2013 | 32 | 0.440 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 99 | 0.430 |
Why?
|
| Fibroadenoma | 1 | 2012 | 27 | 0.400 |
Why?
|
| Healthcare Disparities | 6 | 2024 | 657 | 0.400 |
Why?
|
| Mass Screening | 1 | 2020 | 1547 | 0.390 |
Why?
|
| Phyllodes Tumor | 1 | 2012 | 64 | 0.390 |
Why?
|
| Hyperparathyroidism | 1 | 2010 | 101 | 0.350 |
Why?
|
| Pancreatic Neoplasms | 8 | 2022 | 5258 | 0.350 |
Why?
|
| Postoperative Complications | 8 | 2019 | 5674 | 0.340 |
Why?
|
| Pancreatic Diseases | 3 | 2018 | 113 | 0.330 |
Why?
|
| Parathyroidectomy | 1 | 2010 | 211 | 0.320 |
Why?
|
| Intestinal Obstruction | 2 | 2023 | 224 | 0.320 |
Why?
|
| Retrospective Studies | 31 | 2024 | 39954 | 0.310 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2022 | 1831 | 0.300 |
Why?
|
| Cholecystostomy | 1 | 2007 | 8 | 0.300 |
Why?
|
| Cholecystitis, Acute | 1 | 2007 | 20 | 0.290 |
Why?
|
| Hepatectomy | 3 | 2021 | 1013 | 0.290 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2006 | 370 | 0.270 |
Why?
|
| Prosthesis-Related Infections | 2 | 2006 | 234 | 0.270 |
Why?
|
| Pasteurella multocida | 1 | 2006 | 11 | 0.270 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 1249 | 0.260 |
Why?
|
| Bites and Stings | 1 | 2006 | 44 | 0.260 |
Why?
|
| Carcinoma, Lobular | 1 | 2010 | 622 | 0.260 |
Why?
|
| Venous Thrombosis | 2 | 2020 | 380 | 0.260 |
Why?
|
| Breast Neoplasms | 5 | 2013 | 16242 | 0.250 |
Why?
|
| Rabbits | 1 | 2006 | 1040 | 0.230 |
Why?
|
| Mastectomy, Segmental | 1 | 2010 | 1050 | 0.230 |
Why?
|
| Device Removal | 3 | 2018 | 339 | 0.210 |
Why?
|
| Postoperative Care | 2 | 2019 | 726 | 0.210 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2006 | 349 | 0.200 |
Why?
|
| Databases, Factual | 5 | 2020 | 2258 | 0.200 |
Why?
|
| Rectal Neoplasms | 1 | 2010 | 1240 | 0.200 |
Why?
|
| Middle Aged | 29 | 2024 | 90495 | 0.200 |
Why?
|
| Follow-Up Studies | 11 | 2024 | 15274 | 0.200 |
Why?
|
| Amylases | 2 | 2019 | 67 | 0.190 |
Why?
|
| Liver Transplantation | 2 | 2020 | 1188 | 0.190 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 679 | 0.180 |
Why?
|
| Male | 33 | 2024 | 128446 | 0.180 |
Why?
|
| Female | 33 | 2024 | 148834 | 0.180 |
Why?
|
| Humans | 48 | 2024 | 270637 | 0.180 |
Why?
|
| Aged | 25 | 2024 | 73579 | 0.170 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 588 | 0.170 |
Why?
|
| Stents | 1 | 2006 | 1000 | 0.170 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2020 | 193 | 0.160 |
Why?
|
| Treatment Outcome | 16 | 2019 | 33840 | 0.160 |
Why?
|
| Pancreatic Cyst | 1 | 2019 | 111 | 0.160 |
Why?
|
| Choristoma | 1 | 2018 | 81 | 0.150 |
Why?
|
| Clinical Enzyme Tests | 1 | 2018 | 26 | 0.150 |
Why?
|
| Neoplasm Staging | 7 | 2024 | 14033 | 0.150 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 244 | 0.150 |
Why?
|
| Internship and Residency | 2 | 2020 | 1439 | 0.150 |
Why?
|
| Portal Vein | 1 | 2020 | 363 | 0.150 |
Why?
|
| Minority Groups | 1 | 2020 | 325 | 0.150 |
Why?
|
| Mesenteric Veins | 1 | 2018 | 83 | 0.150 |
Why?
|
| Workload | 1 | 2019 | 193 | 0.140 |
Why?
|
| United States | 11 | 2024 | 15813 | 0.140 |
Why?
|
| General Surgery | 1 | 2020 | 333 | 0.140 |
Why?
|
| Incidental Findings | 1 | 2018 | 283 | 0.140 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 129 | 0.140 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 4837 | 0.140 |
Why?
|
| Nutritional Support | 1 | 2017 | 79 | 0.140 |
Why?
|
| Spleen | 1 | 2018 | 718 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2018 | 476 | 0.130 |
Why?
|
| Adenocarcinoma | 4 | 2017 | 7920 | 0.130 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 1344 | 0.130 |
Why?
|
| Research Design | 2 | 2023 | 1559 | 0.130 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 186 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 307 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 140 | 0.130 |
Why?
|
| Neoplasms | 3 | 2023 | 15949 | 0.120 |
Why?
|
| Hepatitis C | 1 | 2020 | 548 | 0.120 |
Why?
|
| Self Report | 1 | 2019 | 793 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 3 | 2013 | 3187 | 0.120 |
Why?
|
| Disease-Free Survival | 3 | 2023 | 10268 | 0.120 |
Why?
|
| Ultrasonography | 2 | 2013 | 1931 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 1027 | 0.110 |
Why?
|
| Breast | 2 | 2013 | 1370 | 0.110 |
Why?
|
| Recurrence | 2 | 2013 | 4878 | 0.110 |
Why?
|
| Bile | 1 | 2013 | 85 | 0.110 |
Why?
|
| Bile Duct Diseases | 1 | 2013 | 45 | 0.110 |
Why?
|
| Combined Modality Therapy | 4 | 2017 | 9053 | 0.110 |
Why?
|
| Quality of Life | 3 | 2023 | 4806 | 0.110 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 1047 | 0.100 |
Why?
|
| Health Services for the Aged | 1 | 2012 | 54 | 0.100 |
Why?
|
| Adult | 14 | 2018 | 82023 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2015 | 321 | 0.100 |
Why?
|
| Decompression | 1 | 2011 | 12 | 0.100 |
Why?
|
| Erythrocyte Transfusion | 1 | 2013 | 207 | 0.100 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 295 | 0.100 |
Why?
|
| Steroids | 1 | 2013 | 372 | 0.100 |
Why?
|
| Medically Underserved Area | 1 | 2012 | 121 | 0.090 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2012 | 139 | 0.090 |
Why?
|
| Prospective Studies | 7 | 2019 | 13406 | 0.090 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 44 | 0.090 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2011 | 90 | 0.090 |
Why?
|
| Reoperation | 2 | 2018 | 1388 | 0.090 |
Why?
|
| Unnecessary Procedures | 1 | 2011 | 101 | 0.090 |
Why?
|
| Liver | 1 | 2020 | 3057 | 0.090 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 206 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 1301 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 4963 | 0.090 |
Why?
|
| Emigrants and Immigrants | 1 | 2012 | 158 | 0.090 |
Why?
|
| Parathyroid Glands | 1 | 2010 | 127 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 494 | 0.080 |
Why?
|
| Survival Rate | 5 | 2021 | 12528 | 0.080 |
Why?
|
| Prognosis | 6 | 2024 | 22527 | 0.080 |
Why?
|
| Biopsy, Needle | 2 | 2010 | 1381 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 982 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2018 | 9450 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2010 | 414 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2018 | 9278 | 0.070 |
Why?
|
| Palliative Care | 1 | 2019 | 2176 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2012 | 699 | 0.070 |
Why?
|
| Splenic Artery | 1 | 2007 | 54 | 0.070 |
Why?
|
| Mammography | 1 | 2013 | 1055 | 0.070 |
Why?
|
| Time Factors | 6 | 2019 | 12974 | 0.070 |
Why?
|
| Splenic Diseases | 1 | 2007 | 59 | 0.070 |
Why?
|
| Patient Selection | 3 | 2023 | 2029 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 1435 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 31110 | 0.070 |
Why?
|
| Splenectomy | 1 | 2007 | 166 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2017 | 3081 | 0.070 |
Why?
|
| Animals, Domestic | 1 | 2006 | 38 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2012 | 1184 | 0.070 |
Why?
|
| Nutritional Status | 2 | 2019 | 350 | 0.070 |
Why?
|
| Aneurysm, Infected | 1 | 2006 | 29 | 0.060 |
Why?
|
| Preoperative Care | 1 | 2012 | 1581 | 0.060 |
Why?
|
| Biopsy | 1 | 2013 | 3490 | 0.060 |
Why?
|
| Pancreatic Fistula | 2 | 2018 | 102 | 0.060 |
Why?
|
| Abscess | 1 | 2006 | 192 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 4391 | 0.060 |
Why?
|
| Catheterization | 1 | 2007 | 416 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2006 | 151 | 0.060 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 1306 | 0.060 |
Why?
|
| Breast Diseases | 1 | 2006 | 200 | 0.060 |
Why?
|
| Catheters, Indwelling | 1 | 2007 | 382 | 0.060 |
Why?
|
| Registries | 3 | 2019 | 2208 | 0.060 |
Why?
|
| Incidence | 4 | 2019 | 5814 | 0.060 |
Why?
|
| Risk Factors | 6 | 2019 | 17849 | 0.060 |
Why?
|
| Aortic Aneurysm | 1 | 2006 | 218 | 0.050 |
Why?
|
| Length of Stay | 3 | 2018 | 1995 | 0.050 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2002 | 16 | 0.050 |
Why?
|
| Aorta | 1 | 2006 | 666 | 0.050 |
Why?
|
| Disease Progression | 1 | 2013 | 6880 | 0.050 |
Why?
|
| Embolization, Therapeutic | 1 | 2007 | 605 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 2 | 2017 | 5246 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 5093 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 7786 | 0.050 |
Why?
|
| Teaching | 1 | 2002 | 245 | 0.040 |
Why?
|
| Efficiency | 1 | 2020 | 93 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2020 | 107 | 0.040 |
Why?
|
| Hospital Mortality | 2 | 2018 | 1233 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2018 | 4007 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 2656 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2019 | 74 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2023 | 5916 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2019 | 91 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2002 | 424 | 0.040 |
Why?
|
| Pathologists | 1 | 2018 | 101 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2007 | 1302 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2018 | 188 | 0.040 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 38 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2017 | 6765 | 0.040 |
Why?
|
| Propensity Score | 1 | 2020 | 772 | 0.040 |
Why?
|
| Radiologists | 1 | 2018 | 180 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 370 | 0.030 |
Why?
|
| Biomarkers | 2 | 2018 | 5048 | 0.030 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 1257 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2017 | 747 | 0.030 |
Why?
|
| Comorbidity | 2 | 2012 | 2393 | 0.030 |
Why?
|
| Logistic Models | 2 | 2012 | 3423 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 4315 | 0.030 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2014 | 84 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 909 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 703 | 0.030 |
Why?
|
| Malnutrition | 1 | 2017 | 220 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 878 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2018 | 571 | 0.030 |
Why?
|
| Pancreas | 1 | 2017 | 737 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2018 | 824 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2018 | 2272 | 0.030 |
Why?
|
| Age Factors | 2 | 2012 | 5436 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 14638 | 0.030 |
Why?
|
| Surgeons | 1 | 2018 | 493 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 2013 | 265 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 10404 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2013 | 214 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2011 | 20 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2013 | 480 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2011 | 58 | 0.020 |
Why?
|
| Suction | 1 | 2011 | 123 | 0.020 |
Why?
|
| Texas | 2 | 2012 | 6445 | 0.020 |
Why?
|
| Documentation | 1 | 2012 | 213 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2013 | 448 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2017 | 2068 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 4054 | 0.020 |
Why?
|
| Algorithms | 1 | 2019 | 3903 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 4969 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 2297 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 3534 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2007 | 251 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 16740 | 0.020 |
Why?
|
| Urban Population | 1 | 2006 | 275 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 2225 | 0.010 |
Why?
|
| Organizational Case Studies | 1 | 2002 | 36 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6255 | 0.010 |
Why?
|
| Louisiana | 1 | 2002 | 129 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2007 | 871 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 61340 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 22238 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 32687 | 0.000 |
Why?
|
| Child | 1 | 2006 | 30558 | 0.000 |
Why?
|